Innovation and pharmaceutical spending

by Paul Grootendorst, Bob Nakagawa | Mar 31, 2011

Session Resources

Presentation (PDF,  593 KB)

Related Material

Report: Managing pharmaceutical expenditure: Overview and options for Canada

Related Videos

Paul Grootendorst

Aidan Hollis

Gillian Mulvale, CHSRF, Director, Healthcare Financing, Innovation and Transformation

Thursday, March 31, 2011
12:00 p.m. - 1:00 p.m. EST
Call available in English only.

Watch the video


Spending on pharmaceuticals is a fast-growing component of overall healthcare spending in Canada. How can we manage drug spending while encouraging innovation in pharmaceutical technologies? Share your views on proposed policy options!

On February 18th, a small group of invited stakeholders met to discuss policy options for managing brand name and generic drug pricing, while encouraging innovation. On March 31st Researcher on Call will expand the discussion to include policy-makers, stakeholders, researchers and citizens across the country as Paul Grootendorst of the University of Toronto presents the recommendations of an expert paper he coauthored with Aidan Hollis of the University of Calgary. Please join our speakers Paul Grootendorst and Bob Nakagawa propose realistic policy options for Canada!

Featured speakers

GrootendorstPaul Grootendorst, PhD, Associate Professor, Faculty of Pharmacy, University of Toronto

Paul Grootendorst is Associate Professor in the Faculty of Pharmacy and Director of the Division of Clinical, Social and Administrative Pharmacy at the University of Toronto, and Adjunct Associate Professor in the Department of Economics at McMaster University. His research interests are in health economics and applied micro-econometrics. In particular, he examines aspects of pharmaceuticals use, insurance and reimbursement. Paul’s work is supported by a Premier's Research Excellence Award and he held the Rx&D/CIHR Research Career Award in Health Sciences from 2000-2005.

Paul is also a collaborator in the Research Program on the Social and Economic Dimensions of an Aging Population which is major collaborative research program funded by the Social Sciences and Humanities Research Council of Canada. He is the associate editor of Health Economics and serves on the editorial board of Canadian Public Policy.

Paul holds an MA in Economics from Queen’s University and a PhD in Economics from McMaster University. 

Bob NakawagaBob Nakagawa is the Assistant Deputy Minister of Pharmaceutical Services in the Ministry of Health Services in British Columbia.

Bob received his pharmacy degree from UBC and completed a residency at St Paul’s Hospital in Vancouver. He has held leadership positions in regional health authorities, hospitals, government, and the pharmacy profession. This included serving as the President of the College of Pharmacists of BC as well as the Canadian Society of Hospital Pharmacists. He has been instrumental in the development of numerous innovative programs and has received provincial, national and international awards in recognition of his contributions.